1-2 of 2
Henrik Hjorth-Hansen, MD, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Mutation Spectrum of CML Patients Resistant to Imatinib: More Heterogeneous Than Just BCR-ABL Kinase Domain Point Mutations?.

Tuija Lundan, MSc, Franz Gruber, MD, Aleksandra Silye, Henrik Hjorth-Hansen, MD, Ph.D, Ingvild Mikkola, MD, Ph.D, Kari Remes, MD, Ph.D, Bengt Simonsson, MD, Ph.D, Tobias Gedde-Dahl, MD, Ph.D, Kimmo Porkka, MD, Ph.D
Journal: Blood
Blood (2007) 110 (11): 1948.
https://doi.org/10.1182/blood.V110.11.1948.1948
Published: 2007
Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Hans Boström, MD, PhD, Tuija Lundan, M.Sc., Morten Tolstrup Andersen, M.Sc., Gisela Barbany, MD, Ph.D, Thoas Fioretos, MD, Ph.D, Irina Golovleva, Ph.D, Jon Jonasson, MD, Ph.D, Vesa Juvonen, Ph.D, Mikael Lindlöf, Ph.D, Mats Irgen Olsen, MD, Niels Pallisgaard, Ph.D, Eeva-Riitta Savolainen, MD, Ph.D, Marie Schaffer, MD, Ph.D, Aleksandra Silye, Henrik Hjorth-Hansen, MD, Ph.D, Magnus K. Magnusson, MD, Ph.D, Johann Lanng Nielsen, MD, Ph.D, Kimmo Porkka, MD, Ph.D, Bengt Simonsson, MD, Ph.D, Veli Kairisto, MD
Journal: Blood
Blood (2007) 110 (11): 4559.
https://doi.org/10.1182/blood.V110.11.4559.4559
Published: 2007